ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age
Topic Area [clear]
Experience [clear]
Course Format
SIG
Instructional Level
Results 11 - 20 of 54
Presenter(s): Ivette Cejas, PhD
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: This course examines the social and emotional needs of families and how professionals can effectively support clients and their families across the life span for greater well-being. Building on prior experience, knowledge, and skill within the area of auditory rehabilitation, the session focuses on clinical tools and techniques in areas including screening for depression and anxiety, techniques for parental involvement, and counseling skills in motivational interviewing.
Presenter(s): Kathleen M. Cienkowski, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There has been a renewed interest in the provision of aural rehabilitation (AR) services as part of patient-centered hearing health care. Aural rehabilitation is a holistic approach to the management of hearing loss that may include patient education, fitting of devices, and auditory training exercises. Although audiologists may recognize the benefits of comprehensive AR, questions may remain about how to measure functional outcomes of these services. This course reviews functional outcome assessments for aural rehabilitation and how to incorporate these measures into everyday practice to enhance patient success.
Presenter(s): Ryan McCreery, PhD
Credit(s): PDHs: 2.0, ASHA CEUs*: 0.2
Summary: The Joint Committee on Infant Hearing (JCIH) was established to develop evidence-based guidelines for supporting infants and young children who are deaf or hard of hearing. In 2019, the JCIH published an updated position statement based on expertise from stakeholder groups – including audiologists, SLPs, pediatricians, early intervention providers, otolaryngologists, and professionals from the Deaf community. This course describes the major changes in the JCIH position statement as well as clinical implications for any professional involved in serving children who are deaf or hard of hearing and their families. This course – part of the SIGnature Series – was developed by SIG 9: Hearing and Hearing Disorders in Childhood.
Presenter(s): William H Shapiro, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses auditory brainstem implants (ABI) as an option for individuals who typically cannot benefit from conventional amplification or cochlear implants as they don't have an implantable cochlea or functioning 8th nerve. The session describes the ABI journey from candidacy to surgery to activation and follow-up. The speaker discusses the history of ABI, anatomy of the auditory pathway, interprofessional education and interprofessional practice related to ABI, and ABI clinical trial data.
Presenter(s): Michelle Leigh Arnold, AuD, CCC-A; Debra Dobbs, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Older adults must make important decisions about their end-of-life care, and those with hearing and other communication disorders need special accommodations to participate in these important decisions to the fullest extent possible. This session discusses the communication needs of patients in the final stages of life, including the use of various hearing technologies, such as hearing aids, personal sound amplifiers, and pocket talkers. The presenters discuss tools to facilitate conversations among patients, family members, and caregivers.
Webinar cover image
Presenter(s): Kathleen J Riley, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Cytomegalovirus (CMV) is a common and pervasive virus, and undiagnosed cases can have a range of impacts on children. This on demand webinar will discuss the myths and facts about congenital cytomegalovirus (cCMV) and the key role educational audiologists play in recognizing the connections between student challenges and cCMV. The presenter will also discuss the modes of transmission of CMV and necessary precautions.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Webinar product cover
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This on demand webinar will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
<< 1 2 3 4 5 6 >>